
zzso is strongly associated with conditions such as hypertension, diabetes zzso and zzso that have known adverse health zzso The rising prevalence of obesity threatens to zzso our health care zzso As a result, the need for safe and effective treatment options is zzso Unfortunately, zzso treatment options have been disappointing either because of poor side effect profiles or limited long-term zzso Our goal is to review currently available zzso treatments and the data supporting their use so that practicing physicians may better incorporate them into a comprehensive, long-term treatment strategy for their zzso We focus on zzso and zzso as these are the two medicines approved by the zzso for long-term treatment of zzso In addition, we review briefly agents approved for short-term use as well as agents such as zzso and zzso which have shown some promise as weight loss agents in specific clinical zzso Finally, we highlight one medicine currently in phase III clinical trials, an zzso zzso zzso Given the overwhelming research focus on this disease, it is likely that the coming years will bring more treatment options, raising the chance that our patients will have meaningful and sustained weight zzso 

